Cancer therapy: Tumor suppressor AML2 suppresses the expression of epigenetic regulator MeCP2 via up regulation of its target gene, 13/February, 9.15 am

Cancer therapy: Tumor suppressor AML2 suppresses the expression of epigenetic regulator MeCP2 via up regulation of its target gene, 13/February, 9.15 am

Cancer therapy: Tumor suppressor AML2 suppresses the expression of epigenetic regulator MeCP2 via up regulation of its target gene, 13/February, 9.15 am 150 150 Dr Boomi's Genom-2-Discovery Center

Idea Proposed/Formulated by: Dr L Boominathan Ph.D.

Web: http://genomediscovery.org

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

To cite: Boominathan, Cancer therapy: Tumor suppressor AML2 suppresses the expression of epigenetic regulator MeCP2 via up regulation of its target gene, 13/February, 9.15 am,  Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Courtesy: When you cite drop us a line at info@genomediscovery.org

Share
Start Typing